Congenital limb malformation
MONDO:0019054Also known as: congenital limb malformation
61 clinical trials for this condition and its sub-types, 3 tagged with Congenital limb malformation itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Congenital limb malformation
-
Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types
2 sub-types
- Clubfoot 18 trials Sub-types →
- Familial clubfoot due to 17q23.1q23.2 microduplication 0 trials
-
Acrocephalosyndactyly 0 trials · 13 incl. sub-types
4 sub-types
- Apert syndrome 11 trials Sub-types →
- Saethre-Chotzen syndrome 3 trials
- Acrocephalopolysyndactyly 0 trials · 1 incl. sub-types Sub-types →
- Jackson-Weiss syndrome 0 trials
-
Arthrogryposis syndrome 0 trials · 8 incl. sub-types
6 sub-types
- Distal arthrogryposis 0 trials · 3 incl. sub-types Sub-types →
- Lethal congenital contracture syndrome 0 trials · 3 incl. sub-types Sub-types →
- Arthrogryposis multiplex congenita 1 trial · 2 incl. sub-types Sub-types →
- Multiple pterygium syndrome 0 trials · 1 incl. sub-types Sub-types →
- Congenital amyoplasia 0 trials
- Popliteal pterygium syndrome 0 trials Sub-types →
-
Cornelia de Lange syndrome 4 trials · 5 incl. sub-types
6 sub-types
- Cornelia de Lange syndrome 1 1 trial
- Cornelia de Lange syndrome 2 0 trials
- Cornelia de Lange syndrome 3 0 trials
- Cornelia de Lange syndrome 4 0 trials
- Cornelia de Lange syndrome 5 0 trials
- Cornelia de Lange syndrome 6 0 trials
-
Rubinstein-Taybi syndrome 3 trials
3 sub-types
-
Poland syndrome 2 trials
-
Extensor tendons of finger anomalies 2 trials
-
2q37 microdeletion syndrome 1 trial
-
Duane-radial ray syndrome 1 trial
2 sub-types
-
EEC syndrome 1 trial
-
Femur-fibula-ulna complex 1 trial
-
Laurin-Sandrow syndrome 1 trial
-
Proximal symphalangism 1 trial
2 sub-types
- Proximal symphalangism 1A 0 trials
- Symphalangism, proximal, 1B 0 trials
-
Thalidomide embryopathy 1 trial
-
Acrofacial dysostosis 0 trials · 1 incl. sub-types
14 sub-types
- Postaxial acrofacial dysostosis 1 trial
- Patterson-Stevenson-Fontaine syndrome 0 trials
- SF3B4-related acrofacial dysostosis 0 trials Sub-types →
- Acrocraniofacial dysostosis 0 trials
- Acrofacial dysostosis Cincinnati type 0 trials
- Acrofacial dysostosis Preis type 0 trials
- Acrofacial dysostosis Rodriguez type 0 trials
- Acrofacial dysostosis, Catania type 0 trials
- Acrofacial dysostosis, Kennedy-Teebi type 0 trials
- Acrofacial dysostosis, Palagonia type 0 trials
- Acrofacial dysostosis, Weyers type 0 trials
- Acrofrontofacionasal dysostosis 0 trials Sub-types →
- Acromelic frontonasal dysostosis 0 trials
- Mandibulofacial dysostosis-microcephaly syndrome 0 trials
-
ADULT syndrome 0 trials
-
Adams-Oliver syndrome 0 trials
6 sub-types
- Adams-Oliver syndrome 1 0 trials
- Adams-Oliver syndrome 2 0 trials
- Adams-Oliver syndrome 3 0 trials
- Adams-Oliver syndrome 4 0 trials
- Adams-Oliver syndrome 5 0 trials
- Adams-Oliver syndrome 6 0 trials
-
Al-Gazali syndrome 0 trials
-
Cenani-Lenz syndactyly syndrome 0 trials
-
Cooks syndrome 0 trials
-
EEM syndrome 0 trials
-
Emery-Nelson syndrome 0 trials
-
Fuhrmann syndrome 0 trials
-
Gollop-Wolfgang complex 0 trials
-
Hypoglossia-hypodactyly syndrome 0 trials
-
IVIC syndrome 0 trials
-
Karsch-Neugebauer syndrome 0 trials
-
Keutel syndrome 0 trials
-
Leri pleonosteosis 0 trials
-
Mononen-Karnes-Senac syndrome 0 trials
-
OSLAM syndrome 0 trials
-
Say-field-Coldwell syndrome 0 trials
-
Sugarman brachydactyly 0 trials
-
Townes-Brocks syndrome 0 trials
2 sub-types
- Townes-Brocks syndrome 1 0 trials
- Townes-Brocks syndrome 2 0 trials
-
Acromesomelic dysplasia 2B 0 trials
-
Acropectoral syndrome 0 trials
-
1 sub-type
- Rosselli-Gulienetti syndrome 0 trials
-
Autosomal recessive amelia 0 trials
-
Camptodactyly-taurinuria syndrome 0 trials
-
1 sub-type
- Familial caudal dysgenesis 0 trials Sub-types →
-
Cocoon syndrome 0 trials
-
Crossed polysyndactyly 0 trials
-
Ectrodactyly-polydactyly syndrome 0 trials
-
Femoral-facial syndrome 0 trials
-
Fibular dimelia-diplopodia syndrome 0 trials
-
Hand-foot-genital syndrome 0 trials
-
Heart-hand syndrome 0 trials
6 sub-types
- Carney complex - trismus - pseudocamptodactyly syndrome 0 trials
- Holt-Oram syndrome 0 trials Sub-types →
- Brachydactyly-long thumb syndrome 0 trials
- Heart-hand syndrome type 2 0 trials
- Heart-hand syndrome, Slovenian type 0 trials
- Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome 0 trials
-
Humerus trochlea aplasia 0 trials
-
6 sub-types
- Hyperphosphatasia with intellectual disability syndrome 1 0 trials
- Hyperphosphatasia with intellectual disability syndrome 2 0 trials
- Hyperphosphatasia with intellectual disability syndrome 3 0 trials
- Hyperphosphatasia with intellectual disability syndrome 4 0 trials
- Hyperphosphatasia with intellectual disability syndrome 5 0 trials
- Hyperphosphatasia with intellectual disability syndrome 6 0 trials
-
Lethal faciocardiomelic dysplasia 0 trials
-
Mammary-digital-nail syndrome 0 trials
-
Multiple synostoses syndrome 0 trials
4 sub-types
- Multiple synostoses syndrome 1 0 trials
- Multiple synostoses syndrome 2 0 trials
- Multiple synostoses syndrome 3 0 trials
- Multiple synostoses syndrome 4 0 trials
-
Pelvis-shoulder dysplasia 0 trials
-
Pelviscapular dysplasia 0 trials
-
Phocomelia, Schinzel type 0 trials
-
Postaxial tetramelic oligodactyly 0 trials
-
Radio-renal syndrome 0 trials
-
2 sub-types
-
Rapadilino syndrome 0 trials
-
Tarsal-carpal coalition syndrome 0 trials
-
2 sub-types
- Tetraamelia syndrome 1 0 trials
- Tetraamelia syndrome 2 0 trials
-
Tetramelic monodactyly 0 trials
-
Tibial aplasia-ectrodactyly syndrome 0 trials
3 sub-types
-
Ulnar hypoplasia-split foot syndrome 0 trials
Most studied deeper sub-types
-
Bladder cancer drug combo study halted early
Disease control Stopped earlyThis study looked at whether adding an immunotherapy drug (pembrolizumab) to a targeted therapy (pemigatinib) works better than the targeted therapy alone or standard care for people with advanced bladder cancer that has a specific gene change (FGFR3). The study was stopped early…
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early
Disease control Stopped earlyThis phase 2 study tested the drug pemigatinib in 111 people with advanced solid tumors that have specific FGFR gene mutations or translocations. The goal was to see if the drug could shrink tumors. The trial was terminated early, so the full results are not available.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cancer drug INCB062079 tested in early trial
Disease control Stopped earlyThis early-phase trial tested a new drug called INCB062079 in 25 people with advanced liver cancer and other solid tumors. The main goal was to check safety and find the best dose. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Tiny study on nerve stimulation for pain halted early
Knowledge-focused Stopped earlyThis study looked at a type of spinal cord stimulation (SCS) that doesn't cause tingling, called paresthesia-free SCS, in 10 adults with chronic pain. Researchers wanted to see how well it works and how it affects pain perception. The study was terminated early, so the findings a…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC